ArticleCurrent microbiology2026
Differential Copy Number of Chromosomal bla
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Extended-spectrum β-lactamase-producing Enterobacterales pose a significant public health threat from a One Health perspective. During an investigation of companion dogs and cats in Tokyo, we isolated seven Escherichia coli sequence type ST38 strains with characteristic genetic structures related to cephalosporin resistance, as identified by genomic analysis. All strains carried one to three copies of blaCTX−M−14 on their chromosomes, with one strain carrying one copy on a plasmid. Among the six strains with only chromosomal copies, a higher copy number correlated with increased resistance to ceftazidime and elevated blaCTX−M−14 expression, whereas the doubling times calculated from growth curves remained unchanged. Continuous passaging in the presence of ceftazidime resulted in increased copy numbers in three of the six strains. Notably, these characteristics closely resembled those reported for E. coli strains isolated from human clinical cases in South Korea. This similarity suggests that the copy number amplification mechanisms in blaCTX−M−14-carrying E. coli are more widespread than previously recognized, extend across international borders, and adapt to diverse ecological niches, including those of companion animals. Given that an increased copy number enhances resistance to antimicrobial pressure, these findings highlight the need for prudent antimicrobial use in veterinary medicine.
Indexed as
Identifiers
41711952What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.